Complementary and Alternative Medicine in Government-Funded Health Programs
Total Page:16
File Type:pdf, Size:1020Kb
COMPLEMENTARY AND ALTERNATIVE MEDICINE IN GOVERNMENT-FUNDED HEALTH PROGRAMS HEARING BEFORE THE COMMITTEE ON GOVERNMENT REFORM HOUSE OF REPRESENTATIVES ONE HUNDRED SIXTH CONGRESS FIRST SESSION FEBRUARY 24, 1999 Serial No. 106–4 Printed for the use of the Committee on Government Reform ( Available via the World Wide Web: http://www.house.gov/reform U.S. GOVERNMENT PRINTING OFFICE 56–145 CC WASHINGTON : 1999 VerDate 11-MAY-2000 08:40 May 24, 2001 Jkt 010199 PO 00000 Frm 00001 Fmt 5011 Sfmt 5011 E:\HEARINGS\56145 pfrm09 PsN: 56145 COMMITTEE ON GOVERNMENT REFORM DAN BURTON, Indiana, Chairman BENJAMIN A. GILMAN, New York HENRY A. WAXMAN, California CONSTANCE A. MORELLA, Maryland TOM LANTOS, California CHRISTOPHER SHAYS, Connecticut ROBERT E. WISE, JR., West Virginia ILEANA ROS-LEHTINEN, Florida MAJOR R. OWENS, New York JOHN M. MCHUGH, New York EDOLPHUS TOWNS, New York STEPHEN HORN, California PAUL E. KANJORSKI, Pennsylvania JOHN L. MICA, Florida GARY A. CONDIT, California THOMAS M. DAVIS, Virginia PATSY T. MINK, Hawaii DAVID M. MCINTOSH, Indiana CAROLYN B. MALONEY, New York MARK E. SOUDER, Indiana ELEANOR HOLMES NORTON, Washington, JOE SCARBOROUGH, Florida DC STEVEN C. LATOURETTE, Ohio CHAKA FATTAH, Pennsylvania MARSHALL ‘‘MARK’’ SANFORD, South ELIJAH E. CUMMINGS, Maryland Carolina DENNIS J. KUCINICH, Ohio BOB BARR, Georgia ROD R. BLAGOJEVICH, Illinois DAN MILLER, Florida DANNY K. DAVIS, Illinois ASA HUTCHINSON, Arkansas JOHN F. TIERNEY, Massachusetts LEE TERRY, Nebraska JIM TURNER, Texas JUDY BIGGERT, Illinois THOMAS H. ALLEN, Maine GREG WALDEN, Oregon HAROLD E. FORD, JR., Tennessee DOUG OSE, California ——— PAUL RYAN, Wisconsin BERNARD SANDERS, Vermont JOHN T. DOOLITTLE, California (Independent) HELEN CHENOWETH, Idaho KEVIN BINGER, Staff Director DANIEL R. MOLL, Deputy Staff Director DAVID A. KASS, Deputy Counsel and Parliamentarian CARLA J. MARTIN, Chief Clerk PHIL SCHILIRO, Minority Staff Director (II) VerDate 11-MAY-2000 08:40 May 24, 2001 Jkt 010199 PO 00000 Frm 00002 Fmt 5904 Sfmt 5904 E:\HEARINGS\56145 pfrm09 PsN: 56145 C O N T E N T S Page Hearing held on February 24, 1999 ....................................................................... 1 Statement of: Berman, Brian, M.D., associate professor and director, Program for Com- plementary Medicine, University of Maryland School of Medicine, Balti- more, MD; and Ollie and Barbara Johnson, Dean Ornish Lifestyle patient and spouse, Columbia, SC ............................................................... 71 Kamerow, Douglas, M.D., Director, Center for Health Care Technology, Agency for Health Care Policy Research, Department of Health and Human Services; Thomas V. Holohan, M.D., Chief, Patient Care Serv- ices Officer, Veterans Health Administration; John F. Mazzuchi, Dep- uty Assistant Secretary of Defense for Health Affairs, Clinical and Program Policy, Department of Defense; and Jim Zimble, M.D., presi- dent of the Uniformed Services University for the Health Sciences ........ 98 Ornish, Dean, M.D., president and director, Preventive Medicine Re- search Institute, and clinical professor of medicine, University of Cali- fornia, San Francisco, CA ............................................................................. 46 Seymour, Jane, actress .................................................................................... 26 Letters, statements, etc., submitted for the record by: Berman, Brian, M.D., associate professor and director, Program for Com- plementary Medicine, University of Maryland School of Medicine, Balti- more, MD, prepared statement of ................................................................ 75 Burton, Hon. Dan, a Representative in Congress from the State of Illi- nois: Information concerning saw palmetto ..................................................... 143 Letter dated March 1, 1999 ...................................................................... 140 Prepared statement of ............................................................................... 6 Holohan, Thomas V., M.D., Chief, Patient Care Services Officer, Veterans Health Administration, prepared statement of .......................................... 125 Johnson, Barbara, Dean Ornish Lifestyle spouse, Columbia, SC, prepared statement of ................................................................................................... 83 Johnson, Ollie, Dean Ornish Lifestyle patient, Columbia, SC, prepared statement of ................................................................................................... 89 Kamerow, Douglas, M.D., Director, Center for Health Care Technology, Agency for Health Care Policy Research, Department of Health and Human Services, prepared statement of ..................................................... 101 Mazzuchi, John F., Deputy Assistant Secretary of Defense for Health Affairs, Clinical and Program Policy, Department of Defense; and Jim Zimble, M.D., president of the Uniformed Services University for the Health Sciences: Information concerning FY 98 breast cancer research program ........... 138 Prepared statement of ............................................................................... 111 Ornish, Dean, M.D., president and director, Preventive Medicine Re- search Institute, and clinical professor of medicine, University of Cali- fornia, San Francisco, CA, prepared statement of ..................................... 54 Sanders, Hon. Bernard, a Representative in Congress from the State of Vermont, prepared statement of .............................................................. 23 Scarborough, Hon. Joe, a Representative in Congress from the State of Florida, prepared statement of ................................................................ 15 Seymour, Jane, actress, prepared statement of ............................................. 29 (III) VerDate 11-MAY-2000 08:40 May 24, 2001 Jkt 010199 PO 00000 Frm 00003 Fmt 5904 Sfmt 5904 E:\HEARINGS\56145 pfrm09 PsN: 56145 VerDate 11-MAY-2000 08:40 May 24, 2001 Jkt 010199 PO 00000 Frm 00004 Fmt 5904 Sfmt 5904 E:\HEARINGS\56145 pfrm09 PsN: 56145 COMPLEMENTARY AND ALTERNATIVE MEDI- CINE IN GOVERNMENT-FUNDED HEALTH PROGRAMS WEDNESDAY, FEBRUARY 24, 1999 HOUSE OF REPRESENTATIVES, COMMITTEE ON GOVERNMENT REFORM, Washington, DC. The committee met, pursuant to notice, at 10:18 a.m., in room 2154, Rayburn House Office Building, Hon. Dan Burton (chairman of the committee) presiding. Present: Representatives Burton, Gilman, Morella, Davis, San- ford, Hutchinson, Biggert, Chenoweth, Waxman, Maloney, Norton, Kucinich, and Blagojevich. Staff present: Kevin Binger, staff director; Daniel R. Moll, deputy staff director; Beth Clay, professional staff member; David Kass, deputy counsel and parliamentarian; John Williams, deputy press secretary; Carla J. Martin, chief clerk; Lisa Smith Arafune, deputy chief clerk; Jackie Moran, legislative aide; Phil Schiliro, minority staff director; Phil Barnett, minority chief counsel; Kristin Amerling, Jon Bouker, and Sarah Despres, minority counsels; Karen Lightfoot, minority professional staff member; Ellen Rayner, minority chief clerk; Courtney Cook and Earley Green, minority staff assistants; and Barbara Wentworth, minority research assist- ant. Mr. BURTON. The committee will come to order. We have a Republican conference going on at this time and we’ll probably have Members coming in and out. I was going to wait on them, but because we have a number of witnesses that have time constraints, I thought we would go ahead and get started. A quorum being present, the committee will be called to order. I ask unanimous consent that all Members and witnesses written opening statements be included in the record and without objec- tion, so ordered. Today, we continue our inquiry into American’s access to com- plementary and alternative medicine. Alternative medicine con- tinues to increase in popularity and use in the United States. A 1997 survey in the Journal of the American Medical Association re- vealed that over 42 percent of Americans used at least 1 of 16 al- ternative therapies during the previous year. Last year, we looked primarily at the research area. We focused on the ability of seriously ill patients to get access to FDA-approved clinical trials in alternative medicine. This may be a relatively (1) VerDate 11-MAY-2000 08:40 May 24, 2001 Jkt 010199 PO 00000 Frm 00005 Fmt 6633 Sfmt 6633 E:\HEARINGS\56145 pfrm09 PsN: 56145 2 small percentage of the overall population, but it is one that is des- perately in need of our help. There are millions of Americans who are suffering from terminal or crippling diseases. For many of them, conventional treatments like chemotherapy do not work, or may be fatal themselves. For these people, alternative drugs and therapies are the only ray of hope that they have. I believe in my heart that we have an obliga- tion to those people to invest the money that’s needed into research and clinical trials to find out which treatments work and which ones do not. I believe that if someone is seriously ill and wants to try an experimental drug that safety has been established, the Fed- eral Government has no business in blocking them. After all, it’s their life. I have a special interest in this area because of how my own fam- ily has been affected in just the last few years by cancer. Last Sep- tember and October, I lost both my mother and my father to lung cancer. My wife struggled through breast cancer 5 years ago, and thanks to an experimental alternative cancer treatment, she has been in remission for 5 years.